1TZ logo

InfuSystem Holdings DB:1TZ Stock Report

Last Price

€7.70

Market Cap

€169.4m

7D

0%

1Y

-14.0%

Updated

05 Jan, 2025

Data

Company Financials +

InfuSystem Holdings, Inc.

DB:1TZ Stock Report

Market Cap: €169.4m

1TZ Stock Overview

Through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. More details

1TZ fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance4/6
Financial Health4/6
Dividends0/6

Rewards

Trading at 81.4% below our estimate of its fair value

Earnings are forecast to grow 66.51% per year

Earnings grew by 63.6% over the past year

Analysts in good agreement that stock price will rise by 72%

Risk Analysis

Interest payments are not well covered by earnings

Volatile share price over the past 3 months compared to the German market


My Notes

Capture your thoughts, links and company narrative

InfuSystem Holdings, Inc. Competitors

VITA 34

XTRA:V3V

€71.5m

SYNLAB

HMSE:SYAB

€2.5b

Medios

XTRA:ILM1

€333.7m

M1 Kliniken

XTRA:M12

€309.9m

Price History & Performance

Summary of share price highs, lows and changes for InfuSystem Holdings
Historical stock prices
Current Share PriceUS$7.70
52 Week HighUS$9.05
52 Week LowUS$5.15
Beta1.53
1 Month Change-6.10%
3 Month Change27.27%
1 Year Change-13.97%
3 Year Change-47.26%
5 Year Changen/a
Change since IPO-57.38%

Recent News & Updates

Recent updates

Shareholder Returns

1TZDE HealthcareDE Market
7D0%-0.4%-0.4%
1Y-14.0%16.1%7.9%

Return vs Industry: 1TZ underperformed the German Healthcare industry which returned 16.1% over the past year.

Return vs Market: 1TZ underperformed the German Market which returned 7.9% over the past year.

Price Volatility

Is 1TZ's price volatile compared to industry and market?
1TZ volatility
1TZ Average Weekly Movement8.9%
Healthcare Industry Average Movement5.0%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.8%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 1TZ's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 1TZ's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
2005508Rich DiIoriowww.infusystem.com

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

InfuSystem Holdings, Inc. Fundamentals Summary

How do InfuSystem Holdings's earnings and revenue compare to its market cap?
1TZ fundamental statistics
Market cap€169.41m
Earnings (TTM)€1.44m
Revenue (TTM)€128.85m

117.6x

P/E Ratio

1.3x

P/S Ratio

Is 1TZ overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1TZ income statement (TTM)
RevenueUS$132.78m
Cost of RevenueUS$63.89m
Gross ProfitUS$68.90m
Other ExpensesUS$67.41m
EarningsUS$1.48m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.07
Gross Margin51.89%
Net Profit Margin1.12%
Debt/Equity Ratio50.4%

How did 1TZ perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 13:40
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

InfuSystem Holdings, Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kyle BauserB. Riley Securities, Inc.
Matthew HewittCraig-Hallum Capital Group LLC
Alexander NowakCraig-Hallum Capital Group LLC